| Literature DB >> 21119719 |
Timothy R Coté1, Kui Xu, Anne R Pariser.
Abstract
Interest in developing drugs for rare diseases has increased substantially in recent years. This article from the US Food and Drug Administration highlights the role of regulators in catalysing further progress in this field.Mesh：
Year: 2010 PMID： 21119719 DOI： 10.1038/nrd3340
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694